Pillar-1: Multicenter Phase 2 Study of Everolimus for Patients with Mantle Cell Lymphoma Who Are Refractory or Intolerant to Bortezomib.
| Image |  |
|---|---|
| Description | scholarly article |
| Author/s |
author: Owen A. O'Connor Michael Wang |
| Publication date | November 16, 2012 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Access work | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |